Search Results - "Wusu, Adedoja Dorcas"

The Antioxidant and In Vitro Wound Healing Activity of Cotyledon orbiculata Aqueous Extract and the Synthesized Biogenic Silver Nanoparticles by Tyavambiza, Caroline, Meyer, Mervin, Wusu, Adedoja Dorcas, Madiehe, Abram Madimabe, Meyer, Samantha

“…The synthesis of silver nanoparticles using biogenic methods, particularly plants, has led to the discovery of several effective nanoparticles. In many…”
Get full text

The Cytotoxicity of Cotyledon orbiculata Aqueous Extract and the Biogenic Silver Nanoparticles Derived from the Extract by Tyavambiza, Caroline, Meyer, Mervin, Wusu, Adedoja Dorcas, Madiehe, Abram, Meyer, Samantha

“…Green synthesized silver nanoparticles (AgNPs) have become popular because of their promising biological activities. However, for most of these nanoparticles,…”
Get full text

Oxidative stress and inflammation following sub-lethal oral exposure of cypermethrin in rats: mitigating potential of epicatechin by Afolabi, Olusegun Kayode, Aderibigbe, Felix Adesola, Folarin, Dasola Teslim, Arinola, Abimbola, Wusu, Adedoja Dorcas

“…Cypermethrin (CYP), a synthetic pyrethroid is a common environmental toxicant owing to its wide usage as a broad-spectrum insecticide. Its exposure to…”
Get full text

Citrate-capped gold nanoparticles with a diameter of 14 nm alter the expression of genes associated with stress response, cytoprotection and lipid metabolism in CaCo-2 cells by Wusu, Adedoja Dorcas, Sibuyi, Nicole Remaliah Samantha, Moabelo, Koena Leah, Goboza, Mediline, Madiehe, Abram, Meyer, Mervin

“…Advancements in nanotechnology have provided insight into the unique opportunities for the application of nanomaterials such as gold nanoparticles (AuNPs) in…”
Get more information

Modulation of PON2 and Proinflammatory Cytokine Genes in Rat Tissue Exposed to Combined oral Contraceptive Ethinylestradiol and Levonorgestrel by Wusu, Adedoja Dorcas, Rotimi, Solomin Oladapo, Saibu, Gbemisola Morounke, Rotimi, Oluwakemi Anuoluwapo, Giwa, Rahman Ayodele

“…Abstract only Paraoxonase (PON2) was identified as a genetic risk factor for cardiovascular disease (CVD) and usage of oral contraceptive (OC) is associated…”
Get full text